In glioma cells, downregulation of METTL14 induces down-regulation of m6A modification and expression of circRNA_103239, driving up-regulation of miR-182-5p and down-regulation of MTSS1, thereby promoting EMT in glioma and promoting tumor progression (96). This evidence concerns the gene METTL14 and central nervous system cancer.